Super Bowl Sunday is right around the corner, and our biweekly installment of In the News is the perfect playing field for us to showcase the wide range of research projects that Children’s Hospital of Philadelphia experts tackle. Huddle up!
Category Archive: Mitochondrial-Genetic Disease Clinic
This week we’re all about getting smart in our highlights of research news from The Children’s Hospital of Philadelphia. Getting smart in the approach to tackling childhood cancer means identifying strategies that will make a decade’s progress in half the time.
Researchers at The Children’s Hospital of Philadelphia Research Institute are always curious as they explore uncharted territories and tap new technologies. Read about the many novel ways they are looking to improve children’s health in the February issue of Bench to Bedside.
By using existing human drugs to improve metabolism and restore shortened lifespans in microscopic worms, scientists have set the stage for human clinical trials of possible innovative therapies for mitochondrial disease.
Researchers and physicians at The Children’s Hospital of Philadelphia are part of a transdisciplinary team that will apply sophisticated technology and methodology in molecular biology and genomics to help better understand the basis for preterm birth.
Children’s Hospital researchers recently identified a network of signaling molecules that acts like a “fuse box,” regulating the effects of defective energy flow in mitochondrial respiratory chain diseases.
A team led by CHOP’s Marni J. Falk, MD, has expanded next-generation gene tools designed to sequence nuclear DNA to analyze a separate source of DNA — that found within mitochondria. Mitochondria are key suppliers of the energy needed for the multiple functions of our cells. Mitochondria contain their own DNA, and play a pivotal role in human health and disease.